We demonstrate in primary immune cells, patient explants, and cancer cell models (Figures 3, 4, 5A, C) that STINGPOX induces expression of type I IFNs and downstream gene products (including PD-L1) following production of c-di-AMP. This evidence concerns the gene CD274 and cancer.